ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

PHARM Pharming Group NV

0.743
-0.0075 (-1.00%)
Jun 14 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Pharming Group NV PHARM Euronext Ordinary Share
  Price Change Price Change % Share Price Last Trade
-0.0075 -1.00% 0.743 10:40:00
Open Price Low Price High Price Close Price Previous Close
0.75 0.743 0.759 0.743 0.7505
more quote information »

Recent News

Date Time Source Heading
6/03/202401:00GLOBEPharming Group to participate in June investor conferences
5/30/202415:44GLOBEPharming Group provides update on ongoing regulatory review..
5/21/202410:30GLOBEPharming Group reports on results of the 2024 Annual General..
5/20/202401:00GLOBEPharming Group to participate in May investor conference
5/15/202400:00GLOBEPharming Group announces the early redemption of the..
5/08/202400:00GLOBEPharming Group reports first quarter 2024 financial results..
4/24/202401:00GLOBEPharming Group to report first quarter 2024 financial..
4/24/202400:00GLOBEPharming to be honored as Industry Innovator at National ..
4/19/202411:43GLOBEPharming Group announces the repurchase of outstanding €125..
4/18/202408:04GLOBEPharming Group announces the placement of €100 million..
4/18/202401:00GLOBEPharming Group announces the launch of an offering of..
4/08/202400:00GLOBEPharming announces completion of enrollment in pediatric..
4/04/202401:30GLOBEPharming Group announces the 2024 Annual General Meeting of..
4/04/202400:00GLOBEPharming Group announces the filing of its 2023 Annual..
4/03/202401:00GLOBEPharming Group to participate in April investor conferences
3/14/202401:00GLOBEPharming Group reports fourth quarter and full year 2023..
2/29/202401:00GLOBEPharming Group to report fourth quarter and full year 2023..
2/08/202401:00GLOBEPharming Group to participate in February investor..
1/08/202400:00GLOBEPharming Group announces updated full year 2023 guidance and..
12/13/202300:00GLOBEPharming Group announces development plans for leniolisib..
11/21/202300:00GLOBEPharming announces first patient dosed in pediatric clinical..
11/10/202307:51GLOBEPharming Group provides updates on EMA regulatory review of..
11/01/202302:00GLOBEPharming Group to participate in November investor..
10/26/202300:00GLOBEPharming Group reports third quarter 2023 financial results
10/12/202301:00GLOBEPharming Group to report third quarter 2023 financial..
9/25/202309:00GLOBEPharming Group reports on results of the 2023 Extraordinary..

Your Recent History

Delayed Upgrade Clock